PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial. (P2)
A Multicentre Prospective Natural History Study Using Multimodality Imaging in Patients With ACS- PROSPECT II (Natural History Study), Combined With a Randomized, Controlled, Intervention Study - PROSPECT ABSORB (Randomized Trial)
Sponsor: Abbott Medical Devices
A NA clinical study on Acute Coronary Syndrome (ACS), this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 9 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Sep 2021 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed
▶ Show 4 earlier versions
-
Jul 2020 — Sep 2020 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Dec 2018 — Jul 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
- Infraredx
- The Medicines Company
- Uppsala University
For direct contact, visit the study record on ClinicalTrials.gov .